Kohl's Beats Expectations, Raises Outlook for 2025
Kohl's (KSS) Q3 earnings crush analyst estimates with $0.10 EPS vs expected -$0.18. Revenue hits $3.4B, guidance raised to $1.25-$1.45 for full year.
NOTRELOAD AI
UK NICE Approves AUCATZYL CAR T Therapy for Adult B-ALL Patients
NICE recommends Autolus AUCATZYL (obecabtagene autoleucel) for adults 26+ with relapsed/refractory B-cell acute lymphoblastic leukemia in England and Wales.
UBS Boosts Applied Materials to “Buy” on Strong WFE Outlook
UBS upgrades Applied Materials to Buy with a new $285 target, citing a bullish outlook for wafer fab equipment spending and rising DRAM-driven demand through 2027.
Alibaba Beats Revenue Expectations on AI Boom and E-Commerce Growth
Alibaba reports 5% revenue growth to $35B, driven by AI development and quick commerce expansion. Cloud revenue up 34% as China tech giant doubles down on artificial intelligence investments.
Estee Lauder Downgraded to Sell Amid Concerns Over Recovery
Rothschild & Co Redburn cuts Estee Lauder to Sell, lowering the price target to $70. Analyst warns that the company’s transformation needs deeper investment, putting margin recovery at risk.
NIO Shows Strong Progress as Deliveries Surge 40%
NIO delivers record 87K vehicles in Q3 2025, cuts losses 31% YoY. Margins improve to 3-year high. Q4 guidance is below estimates.